Article Details

AstraZeneca to buy China-based Gracell Biotechnologies in $1.2 billion deal

Retrieved on: 2023-12-26 20:11:58

Tags for this article:

Click the tags to see associated articles and topics

AstraZeneca to buy China-based Gracell Biotechnologies in $1.2 billion deal. View article details on hiswai:

Excerpt

(Reuters) - AstraZeneca said on Tuesday it had agreed to buy China-based Gracell Biotechnologies to support its cell therapy ambitions, in a deal ...

Article found on: whbl.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up